Table 2 The proportion of controls with evidence of infection with HPV, stratified by age, sex and HIV serostatus
| Â | All HPV | Genital HPV | Cutaneous-HPV |
|---|---|---|---|
Age | Â | Â | Â |
15–28 | 27% (3/11) | 27% (3/11) | 9% (1/11) |
29–32 | 33% (3/9) | 33% (3/9) | 0% (0/9) |
33–70 | 56% (5/9) | 56% (5/9) | 0% (0/9) |
Sex | Â | Â | Â |
Male | 29% (4/14) | 29% (4/14) | 0% (0/14) |
Female | 47% (7/15) | 47% (7/15) | 7% (1/15) |
HIV serostatus | Â | Â | Â |
Negative | 32% (6/19) | 32% (6/19) | 0% (0/19) |
Positive | 50% (5/10) | 50% (5/10) | 10% (1/10) |
TOTAL | 38% (11/29) | 38% (11/29) | 3% (1/29) |